Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ: MNMD )

6.335 +0.035 (+0.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
Psychedelic Stock Gainers And Losers From March 7, 2022
GAINERS: GH Research (NASDAQ: 
Via Benzinga
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
Via Investor Brand Network
Psychedelic Stock Gainers And Losers From March 4, 2022
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
MindMed Converts Shares To Have A Single Class
Psychedelics-focused biopharma company Mind Medicine Inc. (NASDAQ: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 3, 2022
GAINERS: Seelos Therapeutics (NASDAQ: 
Via Benzinga
LSD And Magic Mushroom's Active Compound Appear To Have The Same Effects, New Study Finds
A new peer-reviewed study compared the effects of LSD and psilocybin, two substances currently standing as top molecules behind the recent psychede... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2022
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
Psychedelic Therapies Offer Hope For Mental Health
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
Via Benzinga
Psychedelic Therapies Offer Hope for Mental Health
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
NetworkNewsWire Editorial Coverage New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of... 
Via FinancialNewsMedia
Psychedelic Stock Gainers And Losers From March 1, 2022
GAINERS: Cybin (AMEX: 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2022
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Psychedelic & Marijuana Drug Stocks Continue To Decline
This article updates the latest stock performances of the 13 clinical-stage companies with the largest market capitalizations which are tracked in the munKNEE Pure-Play Marijuana (4) and the munKNEE... 
Via Talk Markets
Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 24, 2022
GAINERS: Seelos Therapeutics (NASDAQ: 
Via Benzinga
Small Pharma, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC: 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2022
GAINERS: LOSERS: Mindset Pharma (OTC: 
Via Benzinga
Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week
An update on the stock performances of the 13 clinical-stage psychedelic and marijuana drug companies with the largest market capitalizations.tttttttttt 
Via Talk Markets
Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 17, 2022
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education
Psychedelics-focused biotech company Cybin Inc. (NYSE:CYBN) ... 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2022
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 14, 2022
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Psychedelic And Cannabis Drug Stocks Continue Advance
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
Via Talk Markets
Mind Medicine, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC: RVVTF) shares closed up 2.51% at $0.22 LOSERS: Mind Medicine (NASDAQ: MNMD) shares closed down 8.09% at $1.25 Cybin (AMEX:CYBN) shares closed down 6.25% at $1.05 ATAI... 
Via Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 7.39% at $1.89 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 9, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 14.29% at $5.76 
Via Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,... 
Via Benzinga
Cathie Wood Is Buying this Peter Thiel-Backed Psychedelics Stock For Ark Funds
There’s a new psychedelics company being added to an ETF from Cathie Wood. What Happened: The Ark Genomic Revolution ETF (BATS: ARKG) took an initial position in shares of... 
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.